NEW YORK--(BUSINESS WIRE)--Exome Asset Management (“Exome”), an innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, today announced it has been shortlisted for the Pension Bridge Institutional Asset Management Awards 2021 in the categories of Active Global Equity Strategy of the Year and Emerging Markets Equity Strategy of the Year.
Exome practices two active investment strategies: one which invests broadly across worldwide healthcare subsectors and geographies, and another that is a specialized healthcare investment fund with an emphasis on public company opportunities in emerging markets. The firm holds both long and short positions in companies that are broadly diversified by geography and healthcare subsector.
“We are honored that Exome has been included on the shortlist of the Pension Bridge Institutional Asset Management Awards, a testament to our firm’s performance over the last year,” said Sam Isaly, Managing Partner and Founder of Exome Asset Management. “Rapid change and technological advances in the healthcare industry have created an exquisite palette of investment opportunities on a worldwide basis, which we believe shapes a compelling investment thesis. Our overarching philosophy is to select what we believe to be the best and most innovative healthcare investments, in any subsector, anywhere in the world.”
The Pension Bridge Institutional Asset Management Awards ceremony will take place on September 23, 2021 at the Metropolitan Club in New York City.
Judging is conducted by a panel of independent and impartial judges from the Institutional Community who select the winners by category based on specific quantitative factors (performance return, net AUM growth and number of institutional mandates won, each over designated periods) and certain qualitative factors (including, among other items, ESG/Innovation, key staff turnover and usage of any marketing and sales materials).
About Exome Asset Management
Exome Asset Management is an innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices. Exome employs sound investment strategies and a philosophy developed by Samuel D. Isaly, who has spent the majority of his 45-year career focused on both developed and emerging markets healthcare. For more information, please visit www.exomeasset.com.
